Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SURG-236: Prehabilitation in High-risk Oncologic Surgery: A Prospective Cohort Study

NCT07638410 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT07638410
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07638410 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SURG-236: Prehabilitation in High-risk Oncologic Surgery: A Prospective Cohort Study
Lead sponsor
Fox Chase Cancer Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 15, 2026
Completion date
March 15, 2030
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal surgery complications, bladder cancer, colo-rectal cancer, esophageal cancer, gastric cancer, ovarian cancer, pancreatic cancer